JESSICA THOMPSON: Open Payments
NPI 1225567118 · TYLER, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$501 in 29 payments from 4 companies in 2025. Trend: 2023 $2,095 · 2024 $1,309 · 2025 $501
Food & beverage: $422Education: $79
| Company | Payments | Amount |
|---|---|---|
| GlaxoSmithKline, LLC. | 22 | $221 |
| AstraZeneca Pharmaceuticals LP | 4 | $166 |
| SANOFI-AVENTIS U.S. LLC | 1 | $79 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $35 |
Products named: NUCALA, AIRSUPRA, DUPIXENT, CAPLYTA, TRELEGY ELLIPTA, FASENRA, TEZSPIRE.
Industry payments across TX — which companies pay providers there.
